This compound is a key intermediate in the synthesis of Bexarotene, a retinoid-class medication used for treating cutaneous T-cell lymphoma and other cancers. Its unique tetrahydronaphthalene-benzoic acid structure facilitates chemical modifications to enhance bioavailability and receptor specificity in pharmaceutical applications. It is particularly valued in oncology research for developing apoptosis-inducing agents and in dermatology for anti-acne and anti-inflammatory compounds. Additionally, its conjugated system is investigated for potential roles in advanced materials, though primary applications remain in bioactive molecule synthesis.